Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Moderna’s coronavirus vaccine is 94% effective in preventing symptomatic COVID-19—and it may also reduce asymptomatic infection.
The test is authorized for individuals two years of age or older, including those not showing symptoms.
Pfizer/BioNTech’s coronavirus vaccine is 95% effective for preventing symptomatic illness.
A study analyzed how well people with HIV and their health care providers can navigate the experimental long-acting injectable Cabenuva.
Bamlanivimab is now authorized for nonhospitalized people at high risk for progressing to severe COVID-19.
The antiviral drug is the first treatment for the new coronavirus to be approved in United States.
The new credit card-size rapid antigen test can return results in 15 minutes.
“The SalivaDirect test...is yet another testing innovation game changer that will reduce the demand for scarce testing resources.”
The American Cancer Society now calls for vaccination of girls and boys starting at age 9.
The nondrug is intended to improve the ability of children to pay attention, stay focused and control their behavior.
The FDA approved Oriahnn capsules for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Selpercatinib, the first drug in its class, shrank tumors in over two thirds of previously treated patients.
Tests like the one approved this week can show who is likely to be immune, but it’s not yet clear how long such immunity lasts.
Children are exposed to controlled amounts of Palforzia until they can tolerate the dosage needed to avoid severe allergic reactions.
Acting Commissioner Ned Sharpless will return to lead the National Cancer Institute.
The new indication is for prevention of sexually transmitted HIV, with the exception of transmission via receptive vaginal sex.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.